Skip to Content

Cancers, Volume 12, Issue 1

2020 January - 254 articles

Cover Story: The introduction of immunotherapy marks a step forward in the quest for a cure for multiple myeloma. Monoclonal antibodies that target CD38 (daratumumab) and CS1 (elotuzumab) are highly effective and safe options for young and elderly patients. Daratumumab has been included in many regimens and moved from the relapsed to the frontline setting. Furthermore, antibody-drug conjugates such as belantamab mafodotin (GSK2857916) are also under clinical evaluation. Active immunotherapy, aimed at awakening patients’ immune systems against myeloma cells, is of great interest, with bispecific T cell engagers such as AMG420 proving to be effective in heavily pretreated patients in clinical trials. A number of challenges still remain, including the following: finding the correct timing for these agents during the disease course, understanding the mechanisms of resistance, and identifying the antigens to target myeloma cells. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (254)

  • Article
  • Open Access
26 Citations
5,824 Views
9 Pages

Evaluation of Vascular Patterns Using Contact Endoscopy and Narrow-Band Imaging (CE-NBI) for the Diagnosis of Vocal Fold Malignancy

  • Nikolaos Davaris,
  • Anke Lux,
  • Nazila Esmaeili,
  • Alfredo Illanes,
  • Axel Boese,
  • Michael Friebe and
  • Christoph Arens

20 January 2020

The endoscopic detection of perpendicular vascular changes (PVC) of the vocal folds has been associated with vocal fold cancer, dysplastic lesions, and papillomatosis, according to a classification proposed by the European Laryngological Society (ELS...

(This article belongs to the Special Issue Emerging Concepts in Treatment of Laryngeal Cancer)
  • Article
  • Open Access
8 Citations
5,020 Views
14 Pages

Germline Variants in Driver Genes of Breast Cancer and Their Association with Familial and Early-Onset Breast Cancer Risk in a Chilean Population

  • Alejandro Fernandez-Moya,
  • Sebastian Morales,
  • Trinidad Arancibia,
  • Patricio Gonzalez-Hormazabal,
  • Julio C. Tapia,
  • Raul Godoy-Herrera,
  • Jose Miguel Reyes,
  • Fernando Gomez,
  • Enrique Waugh and
  • Lilian Jara

20 January 2020

The genetic variations responsible for tumorigenesis are called driver mutations. In breast cancer (BC), two studies have demonstrated that germline mutations in driver genes linked to sporadic tumors may also influence BC risk. The present study eva...

(This article belongs to the Special Issue Molecular Genetics of Breast and Ovary Cancer)
  • Article
  • Open Access
45 Citations
7,854 Views
19 Pages

Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells

  • Omar Elaskalani,
  • Alice Domenichini,
  • Norbaini Binti Abdol Razak,
  • Danielle E. Dye,
  • Marco Falasca and
  • Pat Metharom

20 January 2020

Background: Extensive research has reported that extracellular ADP in the tumour microenvironment can stimulate platelets through interaction with the platelet receptor P2Y12. In turn, activated platelets release biological factors supporting cancer...

  • Review
  • Open Access
51 Citations
7,622 Views
12 Pages

Role of Interleukin-34 in Cancer

  • Eleonora Franzè,
  • Carmine Stolfi,
  • Edoardo Troncone,
  • Patrizio Scarozza and
  • Giovanni Monteleone

20 January 2020

Cross-talk between cancer cells and the immune cells occurring in the tumor microenvironment is crucial in promoting signals that foster tumor growth and metastasis. Both cancer cells and immune cells secrete various interleukins (IL), which, either...

(This article belongs to the Special Issue Interleukin in Cancer Pathogenesis and Treatment)
  • Article
  • Open Access
51 Citations
8,121 Views
17 Pages

Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers

  • Martin A. Prusinkiewicz,
  • Steven F. Gameiro,
  • Farhad Ghasemi,
  • Mackenzie J. Dodge,
  • Peter Y. F. Zeng,
  • Hanna Maekebay,
  • John W. Barrett,
  • Anthony C. Nichols and
  • Joe S. Mymryk

20 January 2020

Human papillomavirus (HPV) causes an increasing number of head and neck squamous cell carcinomas (HNSCCs). Altered metabolism contributes to patient prognosis, but the impact of HPV status on HNSCC metabolism remains relatively uncharacterized. We hy...

(This article belongs to the Special Issue Human Papillomavirus and Cancers)
  • Review
  • Open Access
32 Citations
9,454 Views
16 Pages

20 January 2020

The MYB binding protein 1A (MYBBP1A, also known as p160) acts as a co-repressor of multiple transcription factors involved in many physiological processes. Therefore, MYBBP1A acts as a tumor suppressor in multiple aspects related to cell physiology,...

  • Article
  • Open Access
26 Citations
6,854 Views
17 Pages

Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer

  • Filippos Koinis,
  • Paul Corn,
  • Nila Parikh,
  • Jian Song,
  • Ioulia Vardaki,
  • Ioanna Mourkioti,
  • Sue-Hwa Lin,
  • Christopher Logothetis,
  • Theocharis Panaretakis and
  • Gary Gallick

19 January 2020

The overall goal of this study was to elucidate the role of FGFR1 induction in acquired resistance to MET and VEGFR2 inhibition by cabozantinib in prostate cancer (PCa) and leverage this understanding to improve therapy outcomes. The response to cabo...

(This article belongs to the Collection Drug Resistance and Novel Therapies in Cancers)
  • Article
  • Open Access
61 Citations
6,714 Views
13 Pages

19 January 2020

Nonthermal plasma is a promising novel therapy for the alteration of biological and clinical functions of cells and tissues, including apoptosis and inhibition of tumor progression. This therapy generates reactive oxygen and nitrogen species (RONS),...

(This article belongs to the Special Issue Plasma in Cancer Treatment)
  • Article
  • Open Access
23 Citations
4,270 Views
18 Pages

Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification

  • Giovanni Tallini,
  • Antonio De Leo,
  • Andrea Repaci,
  • Dario de Biase,
  • Maria Letizia Bacchi Reggiani,
  • Doriana Di Nanni,
  • Francesca Ambrosi,
  • Cira Di Gioia,
  • Giorgio Grani and
  • Cosimo Durante
  • + 4 authors

19 January 2020

It is unclear whether the site of origin of papillary thyroid microcarcinoma (mPTC) with respect to the thyroid surface has an influence on clinicopathologic parameters. The objectives of the study were to: (i) Accurately measure the mPTC distance fr...

(This article belongs to the Special Issue Thyroid Cancer)
  • Feature Paper
  • Article
  • Open Access
25 Citations
4,630 Views
12 Pages

Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma

  • Amanda Meneses Ferreira Lacombe,
  • Iberê Cauduro Soares,
  • Beatriz Marinho de Paula Mariani,
  • Mirian Yumie Nishi,
  • João Evangelista Bezerra-Neto,
  • Helaine da Silva Charchar,
  • Vania Balderrama Brondani,
  • Fabio Tanno,
  • Victor Srougi and
  • Maria Candida Barisson Villares Fragoso
  • + 8 authors

19 January 2020

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with an unfavorable prognosis. Despite the poor prognosis in the majority of patients, no improvements in treatment strategies have been achieved. Therefore, the discovery of new prognosti...

(This article belongs to the Special Issue Adrenocortical Carcinoma)
  • Review
  • Open Access
124 Citations
14,526 Views
24 Pages

Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic Perspective

  • Mei Shan Ong,
  • Shuo Deng,
  • Clarissa Esmeralda Halim,
  • Wanpei Cai,
  • Tuan Zea Tan,
  • Ruby Yun-Ju Huang,
  • Gautam Sethi,
  • Shing Chuan Hooi,
  • Alan Prem Kumar and
  • Celestial T. Yap

18 January 2020

Cytoskeletal proteins, which consist of different sub-families of proteins including microtubules, actin and intermediate filaments, are essential for survival and cellular processes in both normal as well as cancer cells. However, in cancer cells, t...

(This article belongs to the Special Issue Targeted Cancer Therapy)
  • Article
  • Open Access
22 Citations
5,263 Views
18 Pages

In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression

  • Lucia Santorelli,
  • Giulia Capitoli,
  • Clizia Chinello,
  • Isabella Piga,
  • Francesca Clerici,
  • Vanna Denti,
  • Andrew Smith,
  • Angelica Grasso,
  • Francesca Raimondo and
  • Fulvio Magni
  • + 1 author

18 January 2020

Protein N-glycosylation is one of the most important post-translational modifications and is involved in many biological processes, with aberrant changes in protein N-glycosylation patterns being closely associated with several diseases, including th...

(This article belongs to the Special Issue Renal Cell Carcinoma)
  • Review
  • Open Access
71 Citations
11,536 Views
48 Pages

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers

  • Marie Brachet-Botineau,
  • Marion Polomski,
  • Heidi A. Neubauer,
  • Ludovic Juen,
  • Damien Hédou,
  • Marie-Claude Viaud-Massuard,
  • Gildas Prié and
  • Fabrice Gouilleux

18 January 2020

Signal Transducer and Activator of Transcription (STAT) 3 and 5 are important effectors of cellular transformation, and aberrant STAT3 and STAT5 signaling have been demonstrated in hematopoietic cancers. STAT3 and STAT5 are common targets for differe...

(This article belongs to the Special Issue Targeting STAT3 and STAT5 in Cancer)
  • Article
  • Open Access
57 Citations
7,694 Views
14 Pages

1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages

  • Andrea Casadei-Gardini,
  • Laura Del Coco,
  • Giorgia Marisi,
  • Fabio Conti,
  • Giulia Rovesti,
  • Paola Ulivi,
  • Matteo Canale,
  • Giovanni Luca Frassineti,
  • Francesco Giuseppe Foschi and
  • Anna Maria Giudetti
  • + 2 authors

18 January 2020

The application of non-targeted serum metabolomics profiling represents a noninvasive tool to identify new clinical biomarkers and to provide early diagnostic differentiation, and insight into the pathological mechanisms underlying hepatocellular car...

(This article belongs to the Special Issue Recent Research on Gastrointestinal Carcinoma)
  • Article
  • Open Access
18 Citations
6,062 Views
16 Pages

Mutation Status and Epithelial Differentiation Stratify Recurrence Risk in Chordoid Meningioma—A Multicenter Study with High Prognostic Relevance

  • Maria-Magdalena Georgescu,
  • Anil Nanda,
  • Yan Li,
  • Bret C. Mobley,
  • Phyllis L. Faust,
  • Jack M. Raisanen and
  • Adriana Olar

17 January 2020

Chordoid meningioma is a rare WHO grade II histologic variant. Its molecular alterations or their impact on patient risk stratification have not been fully explored. We performed a multicenter, clinical, histological, and genomic analysis of chordoid...

  • Article
  • Open Access
73 Citations
9,419 Views
19 Pages

Cold Plasma-Treated Ringer’s Saline: A Weapon to Target Osteosarcoma

  • Miguel Mateu-Sanz,
  • Juan Tornín,
  • Bénédicte Brulin,
  • Anna Khlyustova,
  • Maria-Pau Ginebra,
  • Pierre Layrolle and
  • Cristina Canal

17 January 2020

Osteosarcoma (OS) is the main primary bone cancer, presenting poor prognosis and difficult treatment. An innovative therapy may be found in cold plasmas, which show anti-cancer effects related to the generation of reactive oxygen and nitrogen species...

(This article belongs to the Special Issue Plasma in Cancer Treatment)
  • Article
  • Open Access
34 Citations
8,861 Views
14 Pages

Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like Phenotype

  • Arianna Casciati,
  • Mirella Tanori,
  • Rémi Manczak,
  • Sofiane Saada,
  • Barbara Tanno,
  • Paola Giardullo,
  • Elena Porcù,
  • Elena Rampazzo,
  • Luca Persano and
  • Mariateresa Mancuso
  • + 5 authors

17 January 2020

Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Despite the progress of new treatments, the risk of recurrence, morbidity, and death remains significant and the long-term adverse effects in survivors are substantial. The frac...

  • Article
  • Open Access
15 Citations
6,822 Views
19 Pages

Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase

  • S. M. Bakhtiar Ul Islam,
  • Bora Lee,
  • Fen Jiang,
  • Eung-Kyun Kim,
  • Soon Cheol Ahn and
  • Tae-Ho Hwang

17 January 2020

Oncolytic viruses are a promising class of anti-tumor agents; however, concerns regarding uncontrolled viral replication have led to the development of a replication-controllable oncolytic vaccinia virus (OVV). The engineering involves replacing the...

(This article belongs to the Special Issue Oncolytic Virus Therapy Against Cancer)
  • Review
  • Open Access
54 Citations
8,794 Views
22 Pages

RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy

  • Lucía García-Gutiérrez,
  • Stephanie McKenna,
  • Walter Kolch and
  • David Matallanas

17 January 2020

The RASSF1A tumour suppressor is a scaffold protein that is involved in cell signalling. Increasing evidence shows that this protein sits at the crossroad of a complex signalling network, which includes key regulators of cellular homeostasis, such as...

(This article belongs to the Special Issue Targeting Ras/RASSF in Cancer)
  • Article
  • Open Access
16 Citations
6,597 Views
14 Pages

Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?

  • Hana Noskova,
  • Michal Kyr,
  • Karol Pal,
  • Tomas Merta,
  • Peter Mudry,
  • Kristyna Polaskova,
  • Tina Catela Ivkovic,
  • Sona Adamcova,
  • Tekla Hornakova and
  • Ondrej Slaby
  • + 3 authors

17 January 2020

Background: Tumor mutational burden (TMB) is an emerging genomic biomarker in cancer that has been associated with improved response to immune checkpoint inhibitors (ICIs) in adult cancers. It was described that variability in TMB assessment is intro...

(This article belongs to the Special Issue Precision Medicine in Solid Tumors)
  • Article
  • Open Access
16 Citations
5,515 Views
14 Pages

Heterogeneous EGFR, CDK4, MDM4, and PDGFRA Gene Expression Profiles in Primary GBM: No Association with Patient Survival

  • María González-Tablas,
  • Daniel Arandia,
  • María Jara-Acevedo,
  • Álvaro Otero,
  • Ana-Luisa Vital,
  • Carlos Prieto,
  • Nerea González-Garcia,
  • Ana Belén Nieto-Librero,
  • Herminio Tao and
  • María Dolores Tabernero
  • + 5 authors

17 January 2020

Background: The prognostic impact of the expression profile of genes recurrently amplified in glioblastoma multiforme (GBM) remains controversial. Methods: We investigated the RNA gene expression profile of epidermal growth factor receptor (EGFR), cy...

(This article belongs to the Special Issue Brain Tumors)
  • Article
  • Open Access
52 Citations
7,524 Views
18 Pages

Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma

  • Caroline Roelants,
  • Catherine Pillet,
  • Quentin Franquet,
  • Clément Sarrazin,
  • Nicolas Peilleron,
  • Sofia Giacosa,
  • Laurent Guyon,
  • Amina Fontanell,
  • Gaëlle Fiard and
  • Odile Filhol
  • + 3 authors

17 January 2020

Clear cell renal cell carcinoma (ccRCC) is the third type of urologic cancer. At time of diagnosis, 30% of cases are metastatic with no effect of chemotherapy or radiotherapy. Current targeted therapies lead to a high rate of relapse and resistance a...

(This article belongs to the Special Issue Renal Cell Carcinoma)
  • Article
  • Open Access
33 Citations
5,057 Views
16 Pages

17 January 2020

Background: The microarray analysis of whole-genome expression indicated that the gene encoding the protein lumican, which is associated with extracellular matrix (ECM) interaction, was highly expressed in osteotropic lung cancer cell lines with an e...

  • Article
  • Open Access
9 Citations
4,974 Views
10 Pages

17 January 2020

Currently, genetic testing is offered only to women diagnosed with breast cancer who meet a defined set of criteria and is not included as standard-of-care treatment at the time of diagnosis. Thus, a significant number of women diagnosed with breast...

(This article belongs to the Special Issue The Study of Cancer Susceptibility Genes)
  • Article
  • Open Access
43 Citations
5,023 Views
18 Pages

The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity

  • Simona Pellecchia,
  • Romina Sepe,
  • Myriam Decaussin-Petrucci,
  • Cristina Ivan,
  • Masayoshi Shimizu,
  • Carmela Coppola,
  • Domenico Testa,
  • George Adrian Calin,
  • Alfredo Fusco and
  • Pierlorenzo Pallante

17 January 2020

Anaplastic thyroid carcinoma (ATC) represents one the most aggressive neoplasias in humans, and, nowadays, limited advances have been made to extend the survival and reduce the mortality of ATC. Thus, the identification of molecular mechanism underly...

(This article belongs to the Special Issue Thyroid Cancer)
  • Review
  • Open Access
13 Citations
5,914 Views
20 Pages

17 January 2020

Ionising radiation (IR) is commonly used for cancer therapy; however, its potential influence on the metastatic ability of surviving cancer cells exposed directly or indirectly to IR remains controversial. Metastasis is a multistep process by which t...

(This article belongs to the Special Issue New Discoveries in Radiation Science: Selection of Papers from the 44th Congress of the European Radiation Research Society (Pécs, Hungary))
  • Article
  • Open Access
18 Citations
5,708 Views
17 Pages

Loss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo

  • Lindsey R. Conroy,
  • Susan Dougherty,
  • Traci Kruer,
  • Stephanie Metcalf,
  • Pawel Lorkiewicz,
  • Liqing He,
  • Xinmin Yin,
  • Xiang Zhang,
  • Sengodagounder Arumugam and
  • Brian F. Clem
  • + 2 authors

17 January 2020

Dysregulated metabolism is a hallmark of cancer cells and is driven in part by specific genetic alterations in various oncogenes or tumor suppressors. The retinoblastoma protein (pRb) is a tumor suppressor that canonically regulates cell cycle progre...

(This article belongs to the Special Issue Recent Advances in Tumor Suppressor)
  • Article
  • Open Access
22 Citations
6,568 Views
22 Pages

Plasma Membrane Ca2+ ATPase Isoform 4 (PMCA4) Has an Important Role in Numerous Hallmarks of Pancreatic Cancer

  • Pishyaporn Sritangos,
  • Eduardo Pena Alarcon,
  • Andrew D. James,
  • Ahlam Sultan,
  • Daniel A. Richardson and
  • Jason I. E. Bruce

16 January 2020

Pancreatic ductal adenocarcinoma (PDAC) is largely resistant to standard treatments leading to poor patient survival. The expression of plasma membrane calcium ATPase-4 (PMCA4) is reported to modulate key cancer hallmarks including cell migration, gr...

(This article belongs to the Special Issue Targeting Calcium Signaling in Cancer Cells)
  • Article
  • Open Access
78 Citations
5,571 Views
21 Pages

Cell Electropermeabilisation Enhancement by Non-Thermal-Plasma-Treated PBS

  • Thai-Hoa Chung,
  • Augusto Stancampiano,
  • Kyriakos Sklias,
  • Kristaq Gazeli,
  • Franck M. André,
  • Sébastien Dozias,
  • Claire Douat,
  • Jean-Michel Pouvesle,
  • João Santos Sousa and
  • Lluis M. Mir
  • + 1 author

16 January 2020

The effectiveness of electrochemotherapy (ECT) in local eradication of tumours in human and veterinary medicine has been proven. ECT consists of increasing the uptake of cytotoxic drugs by means of pulsed electric fields (PEFs) that transiently perme...

(This article belongs to the Special Issue Plasma in Cancer Treatment)
  • Article
  • Open Access
12 Citations
5,749 Views
17 Pages

Combined Effects of Eicosapentaenoic Acid and Adipocyte Renin–Angiotensin System Inhibition on Breast Cancer Cell Inflammation and Migration

  • Fahmida Rasha,
  • Chanaka Kahathuduwa,
  • Latha Ramalingam,
  • Arelys Hernandez,
  • Hanna Moussa and
  • Naima Moustaid-Moussa

16 January 2020

Obesity is a major risk factor for breast cancer (BC). Obesity-related metabolic alterations such as inflammation and overactivation of the adipose renin–angiotensin system (RAS) may contribute to the progression of BC. Clinically used antihype...

(This article belongs to the Special Issue Role of Natural Bioactive Compounds in the Rise and Fall of Cancers)
  • Review
  • Open Access
23 Citations
5,867 Views
16 Pages

16 January 2020

Soft tissue sarcoma (STS) is a rare component of malignant diseases. STS includes various histological subtypes, and there are some important differences among the different histological subtypes regarding the mutation profile and sensitivity to anti...

(This article belongs to the Special Issue Bone and Soft Tissue Tumors)
  • Article
  • Open Access
21 Citations
4,302 Views
17 Pages

Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers

  • Jee Soo Park,
  • Phillip M. Pierorazio,
  • Ji Hyun Lee,
  • Hyo Jung Lee,
  • Young Soun Lim,
  • Won Sik Jang,
  • Jongchan Kim,
  • Seung Hwan Lee,
  • Koon Ho Rha and
  • Won Sik Ham
  • + 1 author

16 January 2020

The molecular characteristics of early-stage clear cell renal cell carcinomas (ccRCCs) measuring ≤7 cm associated with poor clinical outcomes remain poorly understood. Here, we sought to validate genes associated with ccRCC progression and identif...

  • Article
  • Open Access
20 Citations
5,778 Views
23 Pages

MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer

  • Begoña Alday-Parejo,
  • François Richard,
  • Janine Wörthmüller,
  • Tilman Rau,
  • José A. Galván,
  • Christine Desmedt,
  • Albert Santamaria-Martinez and
  • Curzio Rüegg

16 January 2020

Membrane-associated guanylate kinase (MAGUK) with inverted domain structure-1 (MAGI1) is an intracellular adaptor protein that stabilizes epithelial junctions consistent with a tumor suppressive function in several cancers of epithelial origin. Here...

  • Article
  • Open Access
34 Citations
4,795 Views
16 Pages

16 January 2020

(1) Background: Epithelial–mesenchymal transition (EMT) and cancer cell stemness maintenance (SM) are important factors for cancer metastasis. Although hypoxia has been considered as a possible factor for EMT induction and promotion of SM, stud...

(This article belongs to the Special Issue Microenvironment and Cancer Progression)
  • Article
  • Open Access
81 Citations
11,386 Views
29 Pages

Metformin as Potential Therapy for High-Grade Glioma

  • Marek Mazurek,
  • Jakub Litak,
  • Piotr Kamieniak,
  • Bartłomiej Kulesza,
  • Katarzyna Jonak,
  • Jacek Baj and
  • Cezary Grochowski

15 January 2020

Metformin (MET), 1,1-dimethylbiguanide hydrochloride, is a biguanide drug used as the first-line medication in the treatment of type 2 diabetes. The recent years have brought many observations showing metformin in its new role. The drug, commonly use...

(This article belongs to the Special Issue Recent Advances in Glioblastoma)
  • Article
  • Open Access
27 Citations
5,756 Views
15 Pages

Sphingosine 1-Phosphate Receptor 2 Induces Otoprotective Responses to Cisplatin Treatment

  • Wei Wang,
  • Muthu K. Shanmugam,
  • Ping Xiang,
  • Ting Yu Amelia Yam,
  • Vineet Kumar,
  • Wee Siong Chew,
  • Jing Kai Chang,
  • Muhammad Zulfaqar Bin Ali,
  • Marie J. Y. Reolo and
  • Deron R. Herr
  • + 5 authors

15 January 2020

Ototoxicity is a major adverse effect of platinum-based chemotherapeutics and currently, there remains a lack of United States Food and Drug Administration-approved therapies to prevent or treat this problem. In our study, we examined the role of the...

(This article belongs to the Special Issue The Sphingolipid Pathway in Cancer)
  • Article
  • Open Access
29 Citations
4,783 Views
14 Pages

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

  • Maria Tampaki,
  • Evangelos Ionas,
  • Emilia Hadziyannis,
  • Melanie Deutsch,
  • Katerina Malagari and
  • John Koskinas

15 January 2020

Considering the increasing importance of immune checkpoints in tumor immunity we investigated the clinical relevance of serum T-cell immunoglobulin and mucin domain-3 (TIM-3) in patients with hepatocellular carcinoma (HCC). Serum TIM-3 levels were me...

(This article belongs to the Special Issue Human Hepatocellular Carcinoma (HCC))
  • Review
  • Open Access
48 Citations
6,600 Views
26 Pages

Nanodrug Delivery Systems for the Treatment of Ovarian Cancer

  • Jonathan M. Pantshwa,
  • Pierre P. D. Kondiah,
  • Yahya E. Choonara,
  • Thashree Marimuthu and
  • Viness Pillay

15 January 2020

Despite advances achieved in medicine, chemotherapeutics still has detrimental side effects with ovarian cancer (OC), accounting for numerous deaths among females. The provision of safe, early detection and active treatment of OC remains a challenge,...

(This article belongs to the Special Issue Cancer Nanomedicine)
  • Article
  • Open Access
12 Citations
4,883 Views
11 Pages

Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic

  • David Hui,
  • Eman Abdelghani,
  • Joseph Chen,
  • Shiva Dibaj,
  • Donna Zhukovsky,
  • Rony Dev,
  • Kimberson Tanco,
  • Ali Haider,
  • Ahsan Azhar and
  • Eduardo Bruera
  • + 8 authors

15 January 2020

Palliative care is seeing cancer patients earlier in the disease trajectory with a multitude of chronic issues. Chronic non-malignant pain (CNMP) in cancer patients is under-studied. In this prospective study, we examined the prevalence and managemen...

  • Article
  • Open Access
15 Citations
6,096 Views
20 Pages

Heat Shock Protein 90 Chaperone Regulates the E3 Ubiquitin-Ligase Hakai Protein Stability

  • Andrea Díaz-Díaz,
  • Daniel Roca-Lema,
  • Alba Casas-Pais,
  • Gabriela Romay,
  • Giovanni Colombo,
  • Ángel Concha,
  • Begoña Graña and
  • Angélica Figueroa

15 January 2020

The E3 ubiquitin-ligase Hakai binds to several tyrosine-phosphorylated Src substrates, including the hallmark of the epithelial-to-mesenchymal transition E-cadherin, and signals for degradation of its specific targets. Hakai is highly expressed in se...

(This article belongs to the Special Issue Targeting Therapy for Colon Cancer)
  • Article
  • Open Access
40 Citations
6,202 Views
17 Pages

Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer

  • Olga S. Kolovskaya,
  • Tatiana N. Zamay,
  • Galina S. Zamay,
  • Vasily A. Babkin,
  • Elena N. Medvedeva,
  • Nadezhda A. Neverova,
  • Andrey K. Kirichenko,
  • Sergey S. Zamay,
  • Ivan N. Lapin and
  • Anna S. Kichkailo
  • + 11 authors

15 January 2020

Nanotechnologies involving physical methods of tumor destruction using functional oligonucleotides are promising for targeted cancer therapy. Our study presents magnetodynamic therapy for selective elimination of tumor cells in vivo using DNA aptamer...

(This article belongs to the Special Issue The Role of Aptamers in Cancer Diagnostics and Therapy)
  • Article
  • Open Access
34 Citations
5,544 Views
17 Pages

L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population

  • Nastassja Terraneo,
  • Francis Jacob,
  • Claudia Peitzsch,
  • Anna Dubrovska,
  • Christiane Krudewig,
  • Yen-Lin Huang,
  • Viola Heinzelmann-Schwarz,
  • Roger Schibli,
  • Martin Béhé and
  • Jürgen Grünberg

15 January 2020

Many solid tumors, including ovarian cancer, contain small populations of cancer stem cells (CSCs). These cells are usually resistant against conventional cancer therapies and play a role in disease recurrence. We demonstrated that the L1 cell adhesi...

(This article belongs to the Special Issue Molecular Biology of Ovarian Cancer: From Mechanisms of Intraperitoneal Metastasis to Therapeutic Opportunities)
  • Article
  • Open Access
111 Citations
4,643 Views
12 Pages

14 January 2020

Targeting cancer stem cells (CSCs) without damaging normal stem cells could contribute to the development of novel radical cancer therapies. Cells expressing leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) constitute a cancer-causi...

(This article belongs to the Special Issue Photodynamic Therapy (PDT) in Oncology)
  • Review
  • Open Access
28 Citations
6,860 Views
18 Pages

The Communication between the PI3K/AKT/mTOR Pathway and Y-Box Binding Protein-1 in Gynecological Cancer

  • Monika Sobočan,
  • Suzana Bračič,
  • Jure Knez,
  • Iztok Takač and
  • Johannes Haybaeck

14 January 2020

Studies of the mechanistic (mammalian) target of rapamycin inhibitors (mTOR) represent a step towards the targeted treatment of gynecological cancers. It has been shown that women with increased levels of mTOR signaling pathway targets have worse pro...

(This article belongs to the Special Issue Close links between Cold Shock Proteins and Cancer)
  • Article
  • Open Access
49 Citations
10,509 Views
15 Pages

Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)

  • Katharine Thomas,
  • Brianne A. Voros,
  • Meghan Meadows-Taylor,
  • Matthew P. Smeltzer,
  • Ryan Griffin,
  • J. Philip Boudreaux,
  • Ramcharan Thiagarajan,
  • Eugene A. Woltering and
  • Robert A. Ramirez

14 January 2020

Capecitabine and temozolomide (CAPTEM) have shown promising results in the treatment of neuroendocrine neoplasms (NEN). The aim of this study was to evaluate the outcome and role for CAPTEM in malignant neuroendocrine neoplasms. Data were obtained fr...

  • Article
  • Open Access
42 Citations
6,241 Views
18 Pages

Ubiquitin-Specific Protease 21 Promotes Colorectal Cancer Metastasis by Acting as a Fra-1 Deubiquitinase

  • Sun-Il Yun,
  • Hye Kyung Hong,
  • So-Young Yeo,
  • Seok-Hyung Kim,
  • Yong Beom Cho and
  • Kyeong Kyu Kim

14 January 2020

Fos-related-antigen-1 (Fra-1), a member of the activator protein-1 (AP-1) transcription factor superfamily, has an essential role in cancer progress and metastasis and Fra-1 is considered a therapeutic target in metastatic cancer including metastatic...

(This article belongs to the Special Issue Targeting the Ubiquitin Pathway in Cancer)
  • Article
  • Open Access
7 Citations
4,361 Views
13 Pages

A Novel Cytological Model of B-Cell/Macrophage Biphenotypic Cell Hodgkin Lymphoma in Ganp-Transgenic Mice

  • Yasuhiro Sakai,
  • Andri Rezano,
  • Seiji Okada,
  • Takahiro Ohtsuki,
  • Yoshiaki Kawashima,
  • Tetsuya Tsukamoto,
  • Motoshi Suzuki,
  • Michinori Kohara,
  • Motohiro Takeya and
  • Kazuhiko Kuwahara
  • + 1 author

14 January 2020

Hodgkin lymphoma (HL) is one of the most difficult neoplasms in terms of cytopathological research owing to the lack of established cytological murine models. Although HL is believed to be of lymphoid germinal center B-cell origin, HL cells exhibit u...

(This article belongs to the Special Issue Cytologic Features of Tumor)

of 6

XFacebookLinkedIn
Cancers - ISSN 2072-6694